FDA granted accelerated approval to blinatumomab for the treatment of adult and paediatric patients with B-cell precursor ALL in first or second complete remission with MRD ≥0.1%

 

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply